64761-29-1

Basic information

• Product Name: Benzene, 2-(dimethoxymethyl)-1,3,5-trimethyl-
• CAS NO: 64761-29-1
• Molecular Formula: C12H18O2
• Molecular Weight: 194.274
• Mol File: 64761-29-1.mol

Chemical Properties

• CAS DataBase Reference: Benzene, 2-(dimethoxymethyl)-1,3,5-trimethyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzene, 2-(dimethoxymethyl)-1,3,5-trimethyl-(64761-29-1)
• EPA Substance Registry System: Benzene, 2-(dimethoxymethyl)-1,3,5-trimethyl-(64761-29-1)

Safety Data

• Hazardous Substances Data: 64761-29-1(Hazardous Substances Data)

Upstream product

• 67-56-1 methanol 
• 487-68-3 mesytaldehyde 
• 149-73-5 trimethyl orthoformate 
• 7647-01-0 hydrogenchloride 

Downstream Products

• 883715-12-6 tert-Butyl-[(2R,4S,6S)-6-ethynyl-6-methyl-2-(2,4,6-trimethyl-phenyl)-[1,3]dioxan-4-ylmethoxy]-dimethyl-silane 
• 880349-22-4 (Z)-3-[(2R,4S,6S)-6-Methyl-6-((Z)-4-methyl-5-oxo-pent-3-en-1-ynyl)-2-(2,4,6-trimethyl-phenyl)-[1,3]dioxan-4-yl]-acrylic acid methyl ester 
• 880349-21-3 (Z)-methyl 3-((4S,6S)-2-mesityl-6-methyl-6-((Z)-(4-methyl-5-oxofuran-2(5H)-ylidene)methyl)-1,3-dioxan-4-yl)acrylate 
• 880349-19-9 (Z)-methyl 3-((4S,6S)-6-((Z)-5-hydroxy-4-methylpent-3-en-1-ynyl)-2-mesityl-6-methyl-1,3-dioxan-4-yl)acrylate 
• 880349-20-2 (Z)-5-((4S,6S)-2-mesityl-6-((Z)-3-methoxy-3-oxoprop-1-enyl)-4-methyl-1,3-dioxan-4-yl)-2-methylpent-2-en-4-ynoic acid 
• 880349-14-4 (Z)-5-[(2R,4S,6S)-6-(tert-Butyl-dimethyl-silanyloxymethyl)-4-methyl-2-(2,4,6-trimethyl-phenyl)-[1,3]dioxan-4-yl]-2-methyl-pent-2-en-4-yn-1-ol 
• 880349-15-5 (Z)-5-[(2R,4S,6S)-6-(tert-Butyl-dimethyl-silanyloxymethyl)-4-methyl-2-(2,4,6-trimethyl-phenyl)-[1,3]dioxan-4-yl]-2-methyl-pent-2-en-4-ynoic acid 
• 1114543-34-8 1,5,9-trimesityldipyrromethene 
• 1114543-33-7 C₃₆H₄₀N₂ 
• 1266547-48-1 C₂₂H₃₂O₃Si 
• 1266547-60-7 C₂₅H₄₂O₃Si₂ 
• 1266547-51-6 C₃₃H₃₄O₉ 
• 1266547-50-5 C₃₃H₃₅BrO₉ 
• 105228-53-3 2-[(4R,6S)-6-Hydroxymethyl-2-(2,4,6-trimethyl-phenyl)-[1,3]dioxan-4-ylmethyl]-oxazole-4-carboxylic acid methyl ester 

Relevant articles and documents

NICOTINAMIDE RIBOSIDE AND NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES FOR USE IN THE TREATMENTS OF MITOCHONDRIAL-RELATED DISEASES

Provided herein are compounds of Formula (I): or a pharmaceutically acceptable salt thereof, and compositions comprising such compounds that are useful for increasing the amount of NAD+ in cells. Also disclosed are methods of using the disclosed compounds and compositions for treating mitochondrial-related diseases or disorders.

Enantioselective synthesis of N1999A2

An enantioselective synthetic route to the enediyne antibiotic N1999A2 (1) is described, proceeding in 21 steps (0.4% yield, 77% average yield per step) from (R)-(+)-glycidol. The route involves the convergent assembly of three components: a (1-iodovinyl)